Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

MRI- and ultrasound-based prediction of cancer response to chemotherapy

EF 2015-16

Résumé
Breast cancer is the most common non-skin cancer in Canadian women and the second leading cause of cancer death. Locally-advanced breast cancer (LABC) is an aggressive subtype associated with poor recurrence and survival rates. Treatment typically involves neoadjuvant chemotherapy followed by surgery and radiotherapy. Although complete pathological response to neoadjuvant therapy improves patient survival, conventional anatomic assessment (e.g. physical exam or imaging) cannot reliably determine treatment response early during treatment. By detecting cell death within hours to days of treatment start, ineffective therapies could be switched to more efficacious ones and cure rates improved. Magnetic resonance imaging (MRI) and ultrasound show promise for early detection of cell death. Chemical exchange saturation transfer (CEST) MRI technique and quantitative ultrasound (QUS) can detect cell death in preclinical models. They are particularly interesting because they do not require exogenous contrast and they collect data that is independent of operator.We propose a two part study. The first part will compare the two results from the imaging modalities in a murine model. The second part will assess treatment response in a cohort of women with LABC treated with doxorubicin-based neoadjuvant chemotherapy. We hope to demonstrate that CEST MRI and QUS can accurately predict response rates, allowing personalization and optimization of breast cancer therapy and improving the survival prospects of Canadian women with breast cancer.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
350003
Name
Klein Jonathan
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
MRI- and ultrasound-based prediction of cancer response to chemotherapy
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Apoptosis; Breast Cancer; Cell Death; Cest; Chemotherapr; Imaging; Mri; Necrosis; Quantiative Ultrasound; Ultrasound
Abstract
Breast cancer is the most common non-skin cancer in Canadian women and the second leading cause of cancer death. Locally-advanced breast cancer (LABC) is an aggressive subtype associated with poor recurrence and survival rates. Treatment typically involves neoadjuvant chemotherapy followed by surgery and radiotherapy. Although complete pathological response to neoadjuvant therapy improves patient survival, conventional anatomic assessment (e.g. physical exam or imaging) cannot reliably determine treatment response early during treatment. By detecting cell death within hours to days of treatment start, ineffective therapies could be switched to more efficacious ones and cure rates improved. Magnetic resonance imaging (MRI) and ultrasound show promise for early detection of cell death. Chemical exchange saturation transfer (CEST) MRI technique and quantitative ultrasound (QUS) can detect cell death in preclinical models. They are particularly interesting because they do not require exogenous contrast and they collect data that is independent of operator.We propose a two part study. The first part will compare the two results from the imaging modalities in a murine model. The second part will assess treatment response in a cohort of women with LABC treated with doxorubicin-based neoadjuvant chemotherapy. We hope to demonstrate that CEST MRI and QUS can accurately predict response rates, allowing personalization and optimization of breast cancer therapy and improving the survival prospects of Canadian women with breast cancer.
Competitiondate
201512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Klein, Jonathan
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~